<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01349517</url>
  </required_header>
  <id_info>
    <org_study_id>ZSchest2011001</org_study_id>
    <nct_id>NCT01349517</nct_id>
  </id_info>
  <brief_title>Health-related Quality of Life of Patients With Esophageal Cancer After Surgery</brief_title>
  <official_title>Health-related Quality of Life of Patients With Esophageal Cancer After Surgery in China: A Prospective Cohort Study From Multi-center</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fudan University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>First Hospital of Jilin University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Fujian Medical University Union Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Shanxi Province Cancer Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Wuxi People's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Linyi People's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Fudan University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this multi-center prospective cohort study is to study the health-related
      quality of life (HRQL) together with other outcomes of patients with esophageal cancer after
      surgery in China.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      -  To study the influence of health-related quality of life of patients with esophageal
           cancer before and after surgery.

        -  To compare the impact of different procedures on the the health-related quality of life
           of patients with esophageal cancer.

        -  To compare morbidities and oncological results(3,5- year survival) from different
           procedures.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>May 2011</start_date>
  <completion_date type="Anticipated">December 2016</completion_date>
  <primary_completion_date type="Anticipated">December 2013</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Health related quality of life</measure>
    <time_frame>postoperative 2 year</time_frame>
    <description>Health related quality of life from the different precedure groups (assessed by EORTC QLQ C-30 and OES-18)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Morbidity Mortality Survival rate</measure>
    <time_frame>5 years</time_frame>
    <description>Perioperative morbidity and mortality from the different precedure groups.
3-and 5-year survival rate between the groups.</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">400</enrollment>
  <condition>Esophageal Cancer</condition>
  <arm_group>
    <arm_group_label>MIE Group</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>The patients in this group would perform minimal invasive three-incision subtotal esophagectomy (thoracoscopic and/or laparoscopic)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Three-incision esophagectomy group</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>The patients in this group would perform three-incision subtotal esophagectomy (thoracotomy and laparotomy)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Ivor-Lewis esophagectomy group</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>The patients in this group would underwent Ivor-Lewis esophagectomy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sweet esophagectomy group</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>The patients in this group would underwent Sweet esophagectomy.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>MIE</intervention_name>
    <description>The patients in this group would perform minimal invasive three-incision subtotal esophagectomy (thoracoscopic and/or laparoscopic)</description>
    <arm_group_label>MIE Group</arm_group_label>
    <other_name>esophagectomy</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Three-incision thoracotomy</intervention_name>
    <description>The patients in this group would perform three-incision subtotal esophagectomy (thoracotomy and laparotomy)</description>
    <arm_group_label>Three-incision esophagectomy group</arm_group_label>
    <other_name>esophagectomy</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Ivor-Lewis esophagectomy</intervention_name>
    <description>The patients in this group would underwent Ivor-Lewis esophagectomy</description>
    <arm_group_label>Ivor-Lewis esophagectomy group</arm_group_label>
    <other_name>esophagectomy</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Sweet esophagectomy</intervention_name>
    <description>The patients in this group would underwent Sweet esophagectomy.</description>
    <arm_group_label>Sweet esophagectomy group</arm_group_label>
    <other_name>esophagectomy</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Clinical stage I/II esophageal cancer

          -  Normal blood test of basic metabolism panel

          -  Pulmonary function: FEV1 &gt; 1.2L, FEV1% &gt; 50%, DLCO &gt; 50%

          -  Heart function: NY grade I and grade II

        Exclusion Criteria:

          -  Mental disorders

          -  Combination with other cancers

          -  With a previous history of thoracic or ventral surgery
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>35 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lijie Tan, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Zhongshan Hospital, Fudan University, China</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Tan Lijie, MD</last_name>
    <phone>86-021-64041990</phone>
    <phone_ext>2914</phone_ext>
    <email>tan.lijie@zs-hospital.sh.cn</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Wang Hao, MM</last_name>
    <phone>86-021-64041990</phone>
    <phone_ext>2914</phone_ext>
    <email>wang.hao@zs-hospital.sh.cn</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Zhong Shan Hospital, Fu Dan University</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200032</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Lijie Tan, MD</last_name>
      <phone>86-021-64041990</phone>
      <phone_ext>2914</phone_ext>
      <email>tan.lijie@zs-hospital.sh.cn</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>January 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 3, 2011</study_first_submitted>
  <study_first_submitted_qc>May 5, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 6, 2011</study_first_posted>
  <last_update_submitted>November 10, 2011</last_update_submitted>
  <last_update_submitted_qc>November 10, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 11, 2011</last_update_posted>
  <responsible_party>
    <name_title>Tan Lijie MD, Associate Professor of Surgery</name_title>
    <organization>Zhong Shan Hospital, Fu Dan University, Shanghai, China,</organization>
  </responsible_party>
  <keyword>health-related quality of life(HRQL)</keyword>
  <keyword>Esophageal Cancer</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Esophageal Neoplasms</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Menthol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

